| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Keren-Sandyn García-de-la-Torre, Jacobo Kerbel, Amayrani Cano-Zaragoza, Moisés Mercad. Atypical Course of a Patient With AIP-Positive Acromegaly: From GH Excess to GH Deficiency and Back to GH Excess. JCEM case reports. vol 1. issue 2. 2023-11-01. PMID:37908467. |
we herein present the complex case of a patient with acromegaly due to a mammosomatotrope adenoma, with a germ-line aip (aryl hydrocarbon receptor-interacting protein) mutation, who had a chronic and protracted course of more than 15 years during which he was treated with surgery, somatostatin receptor ligands, dopamine agonist, and the gh receptor antagonist pegvisomant. |
2023-11-01 |
2023-11-08 |
Not clear |
| Caiyan Mo, Liyong Zhon. The effect of acromegaly on thyroid disease. Endocrine journal. 2023-10-25. PMID:37880078. |
long-term stimulation of thyroid follicular epithelium by high growth hormone (gh) and insulin-like growth factor-1 (igf-1) in patients with acromegaly can lead to thyroid dysfunction, goiter, thyroid nodules, and even thyroid cancer and thyroid-associated ophthalmopathy (tao). |
2023-10-25 |
2023-11-08 |
Not clear |
| Ansgar Heck, Kristin Godang, Tove Lekva, Kjersti Norman Markussen, Sara De Vincentis, Thor Ueland, Jens Bollersle. Endocortical Trabecularization in Acromegaly: The Cause for the Paradoxically Increased Vertebral Fracture Risk? JBMR plus. vol 7. issue 10. 2023-10-09. PMID:37808394. |
growth hormone (gh) is nonphysiologically increased in acromegaly, stimulating target tissues directly and indirectly via insulin-like growth factor type 1 (igf-1). |
2023-10-09 |
2023-10-15 |
Not clear |
| Ansgar Heck, Kristin Godang, Tove Lekva, Kjersti Norman Markussen, Sara De Vincentis, Thor Ueland, Jens Bollersle. Endocortical Trabecularization in Acromegaly: The Cause for the Paradoxically Increased Vertebral Fracture Risk? JBMR plus. vol 7. issue 10. 2023-10-09. PMID:37808394. |
despite gh having anabolic effects on bone growth and renewal, the risk of vertebral fractures is paradoxically increased in acromegaly. |
2023-10-09 |
2023-10-15 |
Not clear |
| Jing-Yi Li, Jie Chen, Jun Liu, Su-Zhen Zhan. Simultaneous rectal neuroendocrine tumors and pituitary adenoma: A case report and review of literature. World journal of gastroenterology. vol 29. issue 34. 2023-09-27. PMID:37753367. |
acromegaly, a rare and slowly progressive disorder, usually results from a growth hormone (gh)-secreting pituitary adenoma. |
2023-09-27 |
2023-10-07 |
Not clear |
| Arnika Wydra, Maria Stelmachowska-Banaś, Izabella Czajka-Oranie. Skeletal complications in acromegaly. Reumatologia. vol 61. issue 4. 2023-09-25. PMID:37745143. |
in acromegaly as a consequence of overproduction of gh and ifg-1 and the influence of these hormones on bone osteoblasts, bone metabolism, growth and density increase. |
2023-09-25 |
2023-10-07 |
Not clear |
| Muhammed Batur, Muhammet Derda Özer, Rıfkı Üçler, Erbil Seven, Serek Tekin, Fikret Una. Corneal Parameters, Ocular Biometers, and Retinal and Choroidal Thickness in Acromegaly Patients. Photodiagnosis and photodynamic therapy. 2023-08-28. PMID:37640205. |
to compare ocular findings of acromegaly patients with healthy individuals and investigate the relation of serum levels of insulin-like growth factor (igf-1) along with growth hormone (gh) and pituitary tumor (adenoma) dimensions (td) with specific ocular parameters. |
2023-08-28 |
2023-09-07 |
Not clear |
| Lamei Yang, Chunling Li, Tao Song, Xianquan Zha. Growth hormone proteoformics atlas created to promote predictive, preventive, and personalized approach in overall management of pituitary neuroendocrine tumors. The EPMA journal. vol 14. issue 3. 2023-08-22. PMID:37605654. |
abnormal gh is associated with various gh-related diseases, such as acromegaly, dwarfism, diabetes, and cancer. |
2023-08-22 |
2023-09-07 |
human |
| Saud A Alnaaim, Hayder M Al-Kuraishy, Mohammad Mitran Zailaie, Athanasios Alexiou, Marios Papadakis, Hebatallah M Saad, Gaber El-Saber Batih. The potential link between acromegaly and risk of acute ischemic stroke in patients with pituitary adenoma: a new perspective. Acta neurologica Belgica. 2023-08-16. PMID:37584889. |
acromegaly is an endocrine disorder due to the excess production of growth hormone (gh) from the anterior pituitary gland after closed epiphyseal growth plates. |
2023-08-16 |
2023-09-07 |
Not clear |
| L K Dzeranova, L I Lepeshkina, A S Shutova, M A Perepelova, E A Pigarova, V N Azizyan, P V Akopyan, Е G Przhialkovskaya, G A Melnichenko, N G Mokryshev. [Acromegaly in the differential diagnosis of hearing loss]. Problemy endokrinologii. vol 69. issue 2. 2023-07-14. PMID:37448269. |
acromegaly is a multifactorial neuroendocrine disease caused by hyperproduction of growth hormone (gh). |
2023-07-14 |
2023-08-14 |
Not clear |
| Tongxin Xiao, Rui Jiao, Shengmin Yang, Yi Wang, Xue Bai, Jingya Zhou, Ran Li, Linjie Wang, Hongbo Yang, Yong Yao, Kan Deng, Fengying Gong, Hui Pan, Lian Duan, Huijuan Zh. Incidence and risk factors of cancers in acromegaly: a Chinese single-center retrospective study. Endocrine. 2023-07-13. PMID:37442901. |
to evaluate the incidence of malignancies in acromegaly and to identify risk factors for newly-diagnostic cancers, especially the excessive growth hormone (gh) and insulin-like growth factor-1 (igf-1). |
2023-07-13 |
2023-08-14 |
Not clear |
| M Naveed, N Ain, T Aziz, K Javed, H Ishfaq, S Khalil, M Alharbi, A Alshammari, A F Alasmar. A pharmacophore screening approach of homeopathic phenols for a renovated design of fragment-optimized Bauhiniastatin-1 as a drug against acromegaly. European review for medical and pharmacological sciences. vol 27. issue 12. 2023-07-04. PMID:37401289. |
acromegaly is a fatal and chronic disease that is caused by the abnormal secretion of growth hormone (gh) by the pituitary adenoma or pituitary tumor, resulting in an increased circulated concentration of insulin-like growth factors 1 (igf-1), where in most of the cases it is secreted by a pituitary tumor. |
2023-07-04 |
2023-08-14 |
human |
| Mônica Gadelha, Nelma Verônica Marques, Christhiane Fialho, Cristiane Scaf, Elisa Lamback, Ximene Antunes, Erica Santos, Jaqueline Magalhães, Luiz Eduardo Wildember. Long-term efficacy and safety of pasireotide in patients with acromegaly: 14 years' single-center real-world experience. The Journal of clinical endocrinology and metabolism. 2023-06-26. PMID:37357993. |
acromegaly is a rare, chronic, debilitating disorder caused by prolonged hypersecretion of growth hormone (gh) and overproduction of insulin-like growth factor i (igf-i). |
2023-06-26 |
2023-08-14 |
Not clear |
| F Ceccato, C K Vedolin, G Voltan, G Antonelli, M Barbot, D Basso, D Regazzo, C Scaroni, G Occh. Paradoxical GH increase after oral glucose load in subjects with and without acromegaly. Journal of endocrinological investigation. 2023-06-21. PMID:37344722. |
paradoxical gh increase after oral glucose load in subjects with and without acromegaly. |
2023-06-21 |
2023-08-14 |
human |
| F Ceccato, C K Vedolin, G Voltan, G Antonelli, M Barbot, D Basso, D Regazzo, C Scaroni, G Occh. Paradoxical GH increase after oral glucose load in subjects with and without acromegaly. Journal of endocrinological investigation. 2023-06-21. PMID:37344722. |
here, we evaluated the gh profile in subjects with and without acromegaly aiming to refine the definition of gh-par. |
2023-06-21 |
2023-08-14 |
human |
| Denise Costa, Chiara Pellicano, Valeria Mercuri, Jacopo Maria Arnone, Flavio Rizzo, Giorgia Leodori, Patrizia Gargiulo, Edoardo Rosat. In acromegalic patients the serum levels of interleukin-33 and Resolvin D1 influence skin perfusion of hands: A pilot study. Microvascular research. 2023-06-15. PMID:37321455. |
acromegaly is a rare chronic disease, caused by the over-secretion of growth hormone (gh), that creates a pro-inflammatory state, but the exact mechanisms by which gh or insulin-like growth factor 1 (igf-i) act on inflammatory cells are not fully understood. |
2023-06-15 |
2023-08-14 |
Not clear |
| Sylvia L Asa, Ozgur Mete, Nicole D Riddle, Arie Perr. Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1. Endocrine pathology. 2023-06-02. PMID:37268858. |
acromegaly was the presentation in 26 patients; 2 had central hyperthyroidism associated with growth hormone (gh) excess and one had significantly elevated prolactin (prl). |
2023-06-02 |
2023-08-14 |
Not clear |
| Junwei Guo, Wenhao Cao, Jinmei Luo, Rong Huang, Yi Xia. A retrospective study of the role of hypercapnia in patients with acromegaly. BMC pulmonary medicine. vol 23. issue 1. 2023-05-27. PMID:37244996. |
acromegaly is a multisystemic disease characterized by an excessive release of growth hormone (gh) and insulin-like growth factor-1. |
2023-05-27 |
2023-08-14 |
Not clear |
| Sara Sohail, Waqas Shafiq, Kashif Sajjad, Umal Azmat, Muhammad Atif Navee. Ectopic Acromegaly Secondary to Bronchial Tumour: A Case Report of Rare Occurrence. Journal of cancer & allied specialties. vol 7. issue 1. 2023-05-17. PMID:37197403. |
acromegaly is caused due to the unregulated and sustained overproduction of growth hormone (gh). |
2023-05-17 |
2023-08-14 |
Not clear |
| Nicholas Shoung, Ken K Y H. Managing Estrogen Therapy in the Pituitary Patient. Journal of the Endocrine Society. vol 7. issue 5. 2023-05-05. PMID:37143694. |
the route-dependent effects and potency of estrogen formulations are important considerations for optimizing the management of hypogonadal patients with pituitary disease, in particular gh deficiency and acromegaly. |
2023-05-05 |
2023-08-14 |
human |